040 68334455
WhatsApp
Patient Portal
Home Care
Low Phospholipid-Associated Cholelithiasis: Signs and Care
Low phospholipid-associated cholelithiasis is a rare genetic condition that affects the formation of gallstones in the gallbladder. In this disorder, the composition of bile is altered due to reduced levels of phospholipids, leading to the formation of gallstones.
These gallstones can cause blockages in the bile ducts and may lead to complications such as inflammation of the gallbladder or pancreas. Managing this condition is important to prevent these complications and maintain overall health.
Symptoms of Low Phospholipid-Associated Cholelithiasis
Individuals with low phospholipid-associated cholelithiasis may experience a range of symptoms related to gallstones.
- Abdominal pain
- Nausea
- Vomiting
- Jaundice
- Fever
- Gallbladder inflammation
Get a second opinion from trusted experts and makeconfident, informed decisions.
Get Second OpinionCauses of Low Phospholipid-Associated Cholelithiasis
Low phospholipid-associated cholelithiasis is primarily caused by genetic mutations affecting the secretion and composition of bile components.
- ABCB4 gene mutations
- Decreased secretion of phospholipids in bile
- Imbalance in bile composition
- Genetic predisposition
- Chronic liver disease
Types of Low Phospholipid-Associated Cholelithiasis
Low phospholipid-associated cholelithiasis can manifest in various forms, impacting the gallbladder in distinct ways.
- ABCB4 Gene Mutation: Low phospholipidassociated cholelithiasis caused by mutations in the ABCB4 gene, leading to impaired secretion of phospholipids into bile.
- P4HB Mutation: A rare form of this condition associated with mutations in the P4HB gene, affecting the synthesis and secretion of phospholipids.
- ATP8B1 Deficiency: Low phospholipidassociated cholelithiasis linked to ATP8B1 deficiency, disrupting the transport of phospholipids across cell membranes.
- TJP2 Mutation: Some cases of this condition are due to mutations in the TJP2 gene, impacting the function of tight junction proteins involved in bile formation.
- Other Genetic Variants: In addition to the mentioned types, there may be other genetic variants contributing to low phospholipidassociated cholelithiasis, highlighting the genetic heterogeneity of the condition.
Risk Factors
Low phospholipid-associated cholelithiasis is linked to genetic factors, such as mutations in the ABCB4 gene, which can impair the secretion of phospholipids into the bile, leading to an increased risk of gallstone formation.
- Genetic predisposition
- Young age
- Female gender
- Rapid weight loss
- Total parenteral nutrition
- Chronic hemolysis
- Chronic liver disease
- Use of ceftriaxone
Your health is everything - prioritize your well-being today.
Schedule Your Appointment
Diagnosis of Low Phospholipid-Associated Cholelithiasis
Low phospholipid-associated cholelithiasis is typically diagnosed through a combination of clinical assessment and specific tests.
- Genetic testing
- Imaging tests like ultrasound or MRI
- Blood tests to check for specific markers
- Liver function tests
Treatment for Low Phospholipid-Associated Cholelithiasis
Low phospholipid-associated cholelithiasis is typically managed with a combination of lifestyle modifications and medical interventions to prevent the formation of gallstones.
- Ursodeoxycholic acid (UDCA): UDCA is a medication that can help dissolve gallstones and prevent the formation of new ones in low phospholipidassociated cholelithiasis.
- Cholecystectomy: Surgical removal of the gallbladder may be recommended in severe cases of low phospholipidassociated cholelithiasis to prevent complications.
- Lithotripsy: This procedure uses shock waves to break down gallstones, which can be an alternative treatment option for patients who are not suitable for surgery.
- Dietary modifications: Following a lowfat diet and avoiding foods that trigger gallbladder symptoms may help manage low phospholipidassociated cholelithiasis and reduce the risk of gallstone formation.
- Regular monitoring: Periodic checkups and imaging tests may be necessary to monitor the condition of the gallbladder and gallstones in patients with low phospholipidassociated cholelithiasis.
Still have questions? Speak with our experts now!
040-68334455Frequently Asked Questions
What is low phospholipid-associated cholelithiasis (LPAC)?
LPAC is a rare genetic disorder characterized by the formation of gallstones due to a deficiency in phospholipids in bile.
What are the symptoms of LPAC?
Symptoms of LPAC may include abdominal pain, nausea, vomiting, and jaundice, similar to other types of gallstonerelated conditions.
How is LPAC diagnosed?
LPAC can be diagnosed through imaging tests such as ultrasound, CT scan, or MRI to visualize the gallstones and evaluate the bile ducts.
What treatment options are available for LPAC?
Treatment for LPAC may involve medications to dissolve gallstones, surgical removal of the gallbladder (cholecystectomy), or endoscopic procedures to remove stones from the bile ducts.
Is LPAC hereditary?
Yes, LPAC is a genetic condition that can be inherited in an autosomal dominant pattern, meaning a child has a 50% chance of inheriting the gene mutation from an affected parent.
Feeling unwell?
Request a callback!
